Biogen Idec (BIIB) volatility near historic lows into Goldman upgrade to Buy

Biogen Idec (Nasdaq: BIIB) May call option implied volatility is at 26, July is at 22; below its 26-week average of 31 according to Track Data, suggesting decreasing price movement following an upgrade to Buy from Neutral at Goldman Sachs.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Biogen (BIIB) call put ratio 3.7 calls to 1 put with a focus on September calls
• Ross Stores (ROST) 9K contracts of September 220 puts trade into quarter results
• Broadcom (AVGO) spreader of September 220 and 360 puts